Targeted Treatments for Transthyretin Amyloidosis: Essential Insights for Neurologists

Chair, Sami L. Khella, MD, discusses hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) in this CME activity titled “Targeted Treatments for Transthyretin Amyloidosis: Essential Insights for Neurologists.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3Fek53q. CME credit will be available until August 21, 2026.